secwatch / observer
8-K filed May 21, 2026, 4:01 PM ET ticker RACC CIK 0002118032
other material confidence high sentiment neutral materiality 0.80

Research Alliance Corp III prices $75M IPO; shares start trading May 20

Research Alliance Corp III

Machine-readable event card

schema_version
secwatch.filing_event.v1
accession
0001193125-26-234382
form_type
8-K
ticker
RACC
cik
0002118032
company_name
Research Alliance Corp III
filed_at
2026-05-21T20:01:14+00:00
discovered_at
2026-05-21T20:02:00.437571+00:00
generated_at
2026-05-21T22:29:47.602213+00:00
sec_items
["1.01", "3.02", "5.02", "5.03", "8.01", "9.01"]
event_type
other_material
sentiment
neutral
materiality_score
0.8
calibrated_materiality_score
0.8
confidence
high
secwatch_canonical_url
https://secwatch.observer/filing/0001193125-26-234382
json_url
https://secwatch.observer/filing/0001193125-26-234382.json
markdown_url
https://secwatch.observer/filing/0001193125-26-234382.md
text_url
https://secwatch.observer/filing/0001193125-26-234382.txt
edgar_index_url
https://www.sec.gov/Archives/edgar/data/2118032/000119312526234382/0001193125-26-234382-index.htm
edgar_primary_document_url
https://www.sec.gov/Archives/edgar/data/2118032/000119312526234382/d128014d8k.htm
generated_by_model
deepseek-v4-flash:cloud@v2
review_status
machine_generated
human_reviewed
false
corrected
false
correction_note
null
correction_timestamp
null
superseded_by
null

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Michael F. MacLean

Director
RACC · Research Alliance Corp III
Effective
2026-05-19
Filed
May 21, 2026, 4:01 PM ET
Michael F. MacLean and Timothy J. Miller were appointed to the board of directors of the Company (the “Board”).
Appointed

Timothy J. Miller

Director
RACC · Research Alliance Corp III
Effective
2026-05-19
Filed
May 21, 2026, 4:01 PM ET
Michael F. MacLean and Timothy J. Miller were appointed to the board of directors of the Company (the “Board”).

Source-grounded claims

2f54538173

Michael F. MacLean was appointed as Director at Research Alliance Corp III.

Michael F. MacLean and Timothy J. Miller were appointed to the board of directors of the Company (the “Board”).

SEC 8-K Item 5.02 confidence 0.95 SEC evidence

b262fbc73f

Timothy J. Miller was appointed as Director at Research Alliance Corp III.

Michael F. MacLean and Timothy J. Miller were appointed to the board of directors of the Company (the “Board”).

SEC 8-K Item 5.02 confidence 0.95 SEC evidence

Comparable filings

OHAC

Oceanhawk Acquisition Corp. closes upsized $160M IPO of 16M units at $10/unit

Oceanhawk Acquisition Corp. May 27, 2026, 4:01 PM ET other_material Items 1.01, 3.02, 5.02, 5.03, 8.01, 9.01

same fact type: executive_change same SEC item: 1.01, 3.02, 5.02, 5.03, 8.01, 9.01 same event type: other_material similar materiality

This filing

Michael F. MacLean and Timothy J. Miller were appointed to the board of directors of the Company (the “Board”).

Comparable filing

On May 20, 2026, in connection with the IPO, each of Joseph Durnford, Ernest Miller, Jon Ryan, Mike Maggard, Dan Collingridge-Padbury and Jonathan Nickell (collectively, the “ Directors ”) was appointed to the board of directors of the Company (the “ Board ”).

Filing page SEC filing

FDXF

FedEx Freight completes spin-off from FedEx; $600M drawn, new board and executives appointed

FedEx Freight Holding Company, Inc. June 1, 2026, 6:46 AM ET other_material Items 1.01, 2.03, 3.03, 5.03, 5.01, 5.02, 5.05, 8.01, 9.01

same fact type: executive_change same SEC item: 1.01, 5.02, 5.03, 8.01, 9.01 same event type: other_material similar materiality

This filing

Michael F. MacLean and Timothy J. Miller were appointed to the board of directors of the Company (the “Board”).

Comparable filing

each of John A. Smith, R. Brad Martin, Jeffrey A. Davis, Donald E. Frieson, Stephen E. Gorman, Robert A. King, Cindy J. Miller, Amy J. Salcido, and Samantha M. Smith was appointed to the Board

Filing page SEC filing

FXAC

FortuneX Acquisition closes IPO of 8.625M units at $10/unit, raising $86.25M gross

FortuneX Acquisition Corp May 29, 2026, 5:32 PM ET other_material Items 1.01, 3.02, 5.02, 5.03, 9.01

same fact type: executive_change same SEC item: 1.01, 3.02, 5.02, 5.03, 9.01 same event type: other_material similar materiality

This filing

Michael F. MacLean and Timothy J. Miller were appointed to the board of directors of the Company (the “Board”).

Comparable filing

Effective May 19, 2026, in connection with the effectiveness of the Company’s Registration Statement, Becky Fallon, Sean Michael Deegan, and Robert Labbe became members of the board of directors (the “Board”) of the Company.

Filing page SEC filing

ELOX

Eloxx Pharma: 1-for-11 reverse stock split effective May 29; appoints two independent directors

Eloxx Pharmaceuticals, Inc. June 1, 2026, 7:00 AM ET other_material Items 3.02, 3.03, 5.03, 5.02, 9.01

same fact type: executive_change same SEC item: 3.02, 5.02, 5.03, 9.01 same event type: other_material similar materiality

This filing

Michael F. MacLean and Timothy J. Miller were appointed to the board of directors of the Company (the “Board”).

Comparable filing

the Board of Directors (the “Board”) of Eloxx Pharmaceuticals, Inc. (the “Company”) appointed Stephen W. Webster and Nina Kjellson to fill vacancies on the Board

Filing page SEC filing

CRMT

America's Car-Mart forms special committee for strategic alternatives; appoints new independent director

AMERICAS CARMART INC May 29, 2026, 5:30 PM ET other_material Items 1.01, 5.02, 8.01, 9.01

same fact type: executive_change same SEC item: 1.01, 5.02, 8.01, 9.01 same event type: other_material similar materiality

This filing

Michael F. MacLean and Timothy J. Miller were appointed to the board of directors of the Company (the “Board”).

Comparable filing

On May 22, 2026, the Board increased the size of the Board from nine members to ten members and appointed Adam Paul as an independent director, effective immediately.

Filing page SEC filing

LIXT

Lixte Biotechnology pivots to AI energy infrastructure; appoints Denham Capital founder to board

LIXTE BIOTECHNOLOGY HOLDINGS, INC. June 1, 2026, 8:55 AM ET other_material Items 5.02, 7.01, 9.01

same fact type: executive_change same SEC item: 5.02, 9.01 same event type: other_material similar materiality

This filing

Michael F. MacLean and Timothy J. Miller were appointed to the board of directors of the Company (the “Board”).

Comparable filing

On May 29, 2026, the Board of Directors (the “Board”) of Lixte Biotechnology Holdings, Inc., (the “Company”), appointed Stuart D. Porter to serve as a member of the Board, effective May 29, 2026 with a term expiring at the Company’s 2026 Annual Meeting of Stockholders.

Filing page SEC filing

BRKH

Burtech Acquisition Corp II closes $80M IPO; units begin trading on Nasdaq

BurTech Acquisition Corp II May 26, 2026, 5:20 PM ET other_material Items 1.01, 3.02, 5.02, 5.03, 8.01, 9.01

same fact type: executive_change same SEC item: 1.01, 3.02, 5.02, 5.03, 8.01, 9.01 same event type: other_material

This filing

Michael F. MacLean and Timothy J. Miller were appointed to the board of directors of the Company (the “Board”).

Comparable filing

On May 21, 2026, in connection with the IPO, Shahal M. Khan, Leon Golden, Scott E. Young and Sergey Alekseev were appointed to the board of directors of the Company.

Filing page SEC filing

MVST

Microvast CEO converts $25M loan to equity; CAO Eric Garcia departs

Microvast Holdings, Inc. May 28, 2026, 5:26 PM ET other_material Items 5.02, 8.01, 9.01

same fact type: executive_change same SEC item: 5.02, 8.01, 9.01 same event type: other_material

This filing

Michael F. MacLean and Timothy J. Miller were appointed to the board of directors of the Company (the “Board”).

Comparable filing

On May 27, 2026, Eric N. Garcia ceased to be employed as Chief Accounting Officer of Microvast Holdings, Inc. (the “Company”).

Filing page SEC filing

Source: SEC EDGAR
accession 0001193125-26-234382

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.